Merck (MRK) Long-Term Investments (2016 - 2025)
Historic Long-Term Investments for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.
- Merck's Long-Term Investments rose 9426.09% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 9426.09%. This contributed to the annual value of $463.0 million for FY2024, which is 8373.02% up from last year.
- Merck's Long-Term Investments amounted to $1.1 billion in Q3 2025, which was up 9426.09% from $774.0 million recorded in Q2 2025.
- In the past 5 years, Merck's Long-Term Investments ranged from a high of $1.3 billion in Q3 2023 and a low of $238.0 million during Q2 2022
- Moreover, its 5-year median value for Long-Term Investments was $544.0 million (2021), whereas its average is $660.9 million.
- Its Long-Term Investments has fluctuated over the past 5 years, first surged by 102121.21% in 2021, then crashed by 7829.46% in 2024.
- Over the past 5 years, Merck's Long-Term Investments (Quarter) stood at $370.0 million in 2021, then surged by 174.32% to $1.0 billion in 2022, then crashed by 75.17% to $252.0 million in 2023, then surged by 83.73% to $463.0 million in 2024, then surged by 141.25% to $1.1 billion in 2025.
- Its Long-Term Investments was $1.1 billion in Q3 2025, compared to $774.0 million in Q2 2025 and $616.0 million in Q1 2025.